{
    "organizations": [],
    "uuid": "3191a0d144357d6427b37afaed25a17c9f1b0a17",
    "author": "",
    "url": "https://www.reuters.com/article/brief-zosano-reaches-enrollment-mileston/brief-zosano-reaches-enrollment-milestone-in-m207-adam-long-term-safety-study-idUSFWN1QY0J9",
    "ord_in_thread": 0,
    "title": "BRIEF-Zosano Reaches Enrollment Milestone In M207-Adam Long-Term Safety Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 16, 2018 / 1:09 PM / Updated 10 minutes ago BRIEF-Zosano Reaches Enrollment Milestone In M207-Adam Long-Term Safety Study Reuters Staff March 16 (Reuters) - Zosano Pharma Corp: * ZOSANO REACHES ENROLLMENT MILESTONE IN M207-ADAM LONG-TERM SAFETY STUDY * ZOSANO PHARMA CORP - ‍100TH PATIENT HAS ENROLLED AND RECEIVED M207 IN LONG-TERM SAFETY STUDY FOR ACUTE TREATMENT OF MIGRAINE​ * ZOSANO PHARMA CORP - ‍STUDY WILL EVALUATE AT LEAST 150 PATIENTS FOR SIX MONTHS, AND 50 PATIENTS FOR A YEAR AT 31 SITES IN U.S.​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-16T15:07:00.000+02:00",
    "crawled": "2018-03-16T15:24:45.032+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "reach",
        "enrollment",
        "milestone",
        "safety",
        "study",
        "reuters",
        "staff",
        "march",
        "reuters",
        "zosano",
        "pharma",
        "corp",
        "zosano",
        "reach",
        "enrollment",
        "milestone",
        "safety",
        "study",
        "zosano",
        "pharma",
        "corp",
        "patient",
        "enrolled",
        "received",
        "m207",
        "safety",
        "study",
        "acute",
        "treatment",
        "zosano",
        "pharma",
        "corp",
        "evaluate",
        "least",
        "patient",
        "six",
        "month",
        "patient",
        "year",
        "site",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}